logo-loader
CVE:IPA

ImmunoPrecise Antibodies Ltd

Receive alerts
Market:
CVE
Market Cap:
$43.68 m
Price
$0.65
Change
0.00%
52 weeks high
1.02
52 weeks low
0.53

In brief

ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials.

Insight

Deep dive

ImmunoPrecise Antibodies brings in $9mln to further advance the business at home and abroad

The biotech group revealed it had brought in $9.1mln via an oversubscribed placing

on 09/28/2018